Sino Biological (301047.SZ) released its first three quarters performance, with net profit attributable to the parent company of 142 million yuan, a year-on-year increase of 28.44%.

Zhitong Finance APP News, Sino Biological (301047.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 604 million yuan, up 18.07% year on year; net profit attributable to shareholders of the listed company was 142 million yuan, up 28.44% year on year; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 86.6372 million yuan, up 39.17% year on year; basic earnings per share were 1.1634 yuan.